Month: January 2026

23 Jan 2026

PExA’s transformation journey toward future diagnostics highlighted by MedTech Magazine

MedTech Magazine, Sweden’s only media outlet fully dedicated to medical technology, has recently published an in-depth feature on PExA. Under the headline “PExA on a transformation journey – aiming to bring lung cancer instrumentation to primary care”, the article highlights the company’s exhalation-based technology, which holds potential for future diagnostic applications in respiratory disease. The article…

Read more
14 Jan 2026

PExA granted U.S. patent for sPOT technology developed to enhance analytical capabilities in exhaled breath

PExA has been granted a patent in the United States for the technology the company has developed to increase the concentration of biological material that can be analyzed using PExA’s research instrument. The sPOT technology has previously been granted patent protection in Sweden, and patent applications have been filed in additional markets. PExA has developed…

Read more
09 Jan 2026

PExA’s lung cancer research instrument featured by Aftonbladet, Sweden’s largest news site

Aftonbladet, Sweden’s largest news site, is the latest in a series of major Swedish media outlets to highlight the research conducted by Professor Sandra Lindstedt and her research group at Lund University, where PExA’s patented research instrument is being used. On January 4, the newspaper published an in-depth article describing how Professor Lindstedt and her research group use…

Read more

Archive

Categories